Nasdaq

Novocure: FDA Approves HFE Transducer Arrays For Use With Optune Gio - Quick Facts

(RTTNews) - Novocure (NVCR) announced the FDA approved new Head Flexible Electrode transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme. Novocure ...
Seeking Alpha

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

New flexible arrays are lighter, thinner and designed to improve comfort for Optune Gio users ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug ...
Yahoo Finance

Verasonics Announces Update to Vantage® NXT Research Ultrasound System: Acquisition SDK Programming Model, 3 MHz Matrix Array Transducer

3 MHz Matrix Array Transducer – the M3dV 3 MHz Matrix Array features a new monolithic design that enhances image reconstruction and improves image quality; it utilizes 1024 elements in a 32 x 32 grid ...
ascopubs.org

Transducer array layout optimization for the treatment of pancreatic cancer using Tumor Treating Fields (TTFields) in the phase 3 PANOVA-3 trial.

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: A prospective, randomized, open label, single-center trial.
ascopubs.org

Transducer array layout optimization for treating lung-based tumors with TTFields.

Versatile multigene expression biomarker for predicting clinical platinum sensitivity in non-small cell lung cancer (NSCLC) and ovarian cancer (OC). This is an ASCO Meeting Abstract from the 2015 ASCO ...